Company-wide revenue
Reported revenue in 2021 ¥44.69B Reported revenue in 2025 ¥114.36B
- growth amount
- +¥69.67B
- growth annualized
- +26.5%
- growth total
- +155.9%
Japanese company profile · 3479
In its FY2025 public filing, Teiikeepii reports Space regeneration circulation, Lirica, Novarese-Escri. The page shows business-level revenue and profit where the source disclosures support comparison.
Romanized spelling of the Japanese company name; not an official English name.
Original Japanese company name: 株式会社ティーケーピー
What does this company do?
Teiikeepii's largest reported business by revenue in FY2025 was Space regeneration circulation.
The business with the highest reported segment profit in FY2025 was Space regeneration circulation.
FY2025 · fiscal year ended February 2026 View original filing ↗ The source document may be in Japanese.
Business structure
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Space regeneration circulation | ¥52.28B ↗ | 45.7% | ¥6.75B ↗ |
| Lirica | ¥33.2B ↗ | 29.0% | ¥856M ↗ |
| Novarese-Escri | ¥29.19B ↗ | 25.5% | ¥2.74B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended February 2026. Revenue and profit are shown only where the filing and data support a comparison.
What is growing?
Reported revenue in 2021 ¥44.69B Reported revenue in 2025 ¥114.36B
First reported in 2024
Latest reported revenue ¥52.28B
First reported in 2024
Latest reported revenue ¥33.2B
First reported in 2024
This describes a reported period; it is not a forecast.
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
FY2025 · fiscal year ended February 2026
The source document may be in Japanese.
Filing ID: S100Y7OL
View original filing ↗Ask about this company
The source document may be in Japanese.